SINGAPORE -- As the new coronavirus spreads across the globe and devastates communities, companies are racing to develop a vaccine, with the U.K.'s Emergex becoming the latest to divert resources from other projects, including the development of a dengue fever vaccine, to work on COVID-19.
Startups
Coronavirus vaccine set for testing, says startup backed by Singapore VC
Vickers Venture invests in U.K.'s Emergex as biotechs race to develop drug
Prisoners receive seasonal flu vaccination in Chile in March as the coronavirus outbreak spreads across the globe. © Reuters
Read Next
Latest on Startups
